Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Ocean Biomedical, Inc. | d54742ds1a.htm |
| EX-10.14 - EX-10.14 - Ocean Biomedical, Inc. | d54742dex1014.htm |
| EX-10.7 - EX-10.7 - Ocean Biomedical, Inc. | d54742dex107.htm |
| EX-10.6 - EX-10.6 - Ocean Biomedical, Inc. | d54742dex106.htm |
| EX-10.4 - EX-10.4 - Ocean Biomedical, Inc. | d54742dex104.htm |
| EX-10.3 - EX-10.3 - Ocean Biomedical, Inc. | d54742dex103.htm |
| EX-10.2 - EX-10.2 - Ocean Biomedical, Inc. | d54742dex102.htm |
| EX-10.1 - EX-10.1 - Ocean Biomedical, Inc. | d54742dex101.htm |
| EX-5.1 - EX-5.1 - Ocean Biomedical, Inc. | d54742dex51.htm |
| EX-3.4 - EX-3.4 - Ocean Biomedical, Inc. | d54742dex34.htm |
| EX-3.2 - EX-3.2 - Ocean Biomedical, Inc. | d54742dex32.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-256950 on Form S-1 of our report dated March 5, 2021 (July 13, 2021, as to effects of the forward stock split discussed in Note 11) relating to the financial statements of Ocean Biomedical, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ DELOITTE & TOUCHE LLP
Chicago, Illinois
July 13, 2021